Nuoyimeier (Suzhou) Medical Technology

About Nuoyimeier (Suzhou) Medical Technology

Nuoyimeier (Suzhou) Medical Technology, also known as Neo Modulus, was established in March 2017 through a collaboration of Chinese and German scientists. The company operates in the field of regenerative medicine, focusing on the research, development, and production of implantable medical devices. Its core mission is to facilitate complex tissue regeneration and organ reconstruction.

The firm specializes in creating nanoscale scaffolds for tissue engineering that are designed to guide the targeted growth and differentiation of cells. These scaffolds are developed using advanced techniques like biomimetic additive manufacturing, electrospinning, and 3D printing to create precise pore structures that provide mechanical support and a suitable environment for cell growth. The product line includes membranes, artificial bone, adhesives, and microspheres, which have applications in various clinical fields such as oral medicine, ophthalmology, ENT, and sports medicine. The technology leverages principles of light, heat, and radiation to build these structures, ensuring characteristics like bioactivity, degradability, and histocompatibility.

Neo Modulus serves the medical sector, providing its regenerative products to healthcare professionals and institutions. The business model appears to be centered on the development, manufacturing, and commercialization of these high-tech medical consumables. The company has established multiple R&D and production bases in Suzhou, Weifang, Taicang, and Shanghai, in addition to an overseas laboratory in Freiburg, Germany. A significant milestone was achieved in November 2023 when the company obtained NMPA approval for a Class III registration certificate, and it also launched the first phase of an R&D and production base in Shandong.